<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>
    <link rel="stylesheet" href="style5.css">
</head>

<body>
    <div>
        <h1>Table 1.Stem Cell Companies Active in Ophthalmology</h1>
        <div>
            <table border="1">
                <tr class="header">
                    <th>Company</th>
                    <th>Collaborator(s)</th>
                    <th >Cell Type</th>
                    <th>Application</th>
                </tr>
                <tr>
                    <td class="blue">Advanced Cell Technology Inc.ACT)</td>
                    <td>Oregon Health & Science
                        University (OHSU)
                        <ul>
                            <li>Moorfields Eye Hosp</li>
                            <li>UCLA/Jules Stein</li>
                            <li>Wills Eye Hospital</li>
                            <li>Moorfields Eye Hosp</li>
                            <li>Moorfields Eye Hosp</li>
                        </ul>
                    </td>
                    <td class="red">hESCs</td>
                    <td class="yellow">RPE cells for retinal diseases, including DryAMD NCT01344993 and Stargardt’s NCT01345006
                        NCT01469832
                    </td>
                </tr>

                <tr>
                    <td class="blue">AstraZeneca</td>
                    <td>University of Oxford</td>
                    <td class="red">hESCs</td>
                    <td class="yellow">Diabetic Retinopathy</td>
                </tr>
                <tr>
                    <td class="blue">BetaStem Therapeutics</td>
                    <td>University of Florida</td>
                    <td class="red">CD34+ cells
                        from human
                        cord blood or
                        bone marrow</td>
                    <td class="yellow">Diabetic Retinopathy
                        (in preparation for
                        human clinical trials)
                    </td>
                </tr>

                <tr>
                    <td class="blue">Cell CureNeurosciences
                    </td>
                    <td>TEVA</td>
                    <td class="red">hESCs</td>
                    <td class="yellow">RPE cells for dry AMD</td>
                </tr>

                <tr>
                    <td class="blue">CellSeed France
                        SARL
                    </td>
                    <td>FGK Clinical Reserach GmbH
                        <ul>
                            <li>Universitatsklinkum,
                                Erlangen, Germany
                            </li>
                        </ul>
                    </td>
                    <td class="red">oral mucosa
                        epithelial cells</td>
                    <td class="yellow">CAOMECS* for Corneal
                        tissue repair in those with
                        limbal cell deficiencies
                        NCT01489501
                    </td>
                </tr>

                <tr>
                    <td class="blue">Centre Hospitalier
                        d’Ophth. des
                        Quinze-Vingts,
                        Paris</td>
                    <td>Etablissement Francais du Sang liede-France
                    </td>
                    <td class="red">transplantation
                        of cultured
                        allogenic or
                        autologous
                        limbal stem cells</td>
                    <td class="yellow">limbal stem cell
                        deficiency
                        NCT01619189</td>
                </tr>

                <tr>
                    <td class="blue">CHA Bio &
                        Diostech
                        (S. Korea)</td>
                    <td>Licensee of ACT</td>
                    <td class="red">hESCs</td>
                    <td class="yellow">RPE cells for retinal
                        diseases, including
                        Stargardt’s
                        NCT01625559
                        and
                        Dry AMD
                        NCT01674829</td>
                </tr>


                <tr>
                    <td class="blue">Fundacion Clinic
                        per a la Recerca
                        Biomedica (Spain)</td>
                    <td>
                        <ul>
                            <li>Hospital Clinic
                                Barcelona</li>
                            <li>Instituto Univ. Barraquer</li>
                            <li>Instituto de Microcirugia
                                Ocular</li>
                        </ul>
                    </td>
                    <td class="red">sclerocorneal
                        progenitor cells
                        from the limbus
                    </td>
                    <td class="yellow">Replacement of damaged
                        corneal cells
                        NCT01470573</td>
                </tr>
            </table>
        </div>
    </div>
</body>

</html>